Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact?

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 515-522

  Guo, Yutao ^a,b   Pisters, Ron ^b   Apostolakis, Stavros ^b   Blann, Andrew D ^b   Wang, Haijun ^a   Zhao, Xiaoning ^a   Zhang, Yu ^a   Zhang, Dexian ^a   Ma, Jingling ^a   Wang, Yutang ^a   Lip, Gregory Y H ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Apixaban; Aspirin; Atrial fibrillation; Dabigatran; Stroke prevention; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; CLOPIDOGREL; DABIGATRAN; WARFARIN;

ADULT; AGED; AGING; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CHINESE; COHORT ANALYSIS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

APIXABAN; ASPIRIN; ATRIAL FIBRILLATION; DABIGATRAN; STROKE PREVENTION; WARFARIN;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84883759607     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.187     Document Type: Article

References (41)

1. G.Y. Lip, H.F. Tse, and D.A. Lane Atrial fibrillation Lancet 379 2012 648 661
2. J.J. You, D.E. Singer, and P.A. Howard American College of Chest Physicians. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e531S e575S
3. European Heart Rhythm Association European Association for Cardio-Thoracic Surgery A.J. Camm Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
4. G.Y. Lip, C.M. Brechin, and D.A. Lane The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions outside North America and Europe Chest 142 2012 1489 1498
5. X. Zhang, S. Zhang, and Y. Li Association of obesity and atrial fibrillation among middle-aged and elderly Chinese Int J Obes (Lond) 33 2009 1318 1325
6. Z. Zhou, and D. Hu An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China J Epidemiol 18 2008 209 216
7. S. Uchiyama, Y. Shibata, and T. Hirabayashi Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry J Stroke Cerebrovasc Dis 19 2010 190 197
8. K.B. Yap, T.P. Ng, and H.Y. Ong Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study J Electrocardiol 41 2008 94 98
9. L.J. Lin, M.H. Cheng, C.H. Lee, D.C. Wung, C.L. Cheng, and Y.H. Kao Yang Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation - a nationwide descriptive study in Taiwan Clin Ther 30 2008 1726 1736
10. Y. Sun, D. Hu, K. Li, and Z. Zhou Predictors of stroke risk in native Chinese with nonrheumatic atrial fibrillation: retrospective investigation of hospitalized patients Clin Cardiol 32 2009 76 81
11. D.Y. Hu, Y.H. Sun, and Z.Q. Zhou Risk factors for stroke in Chinese with non valvular atrial fibrillation: a case-control study Chin J Intern Med 42 2003 157 161
12. Society of Cardiology (Chinese Medical Association) Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China Chin Med J (Engl) 117 2004 1763 1767
13. K.L. Chien, T.C. Su, and H.C. Hsu Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese Int J Cardiol 139 2010 173 180
14. F.I. Hsieh, L.M. Lien, and S.T. Chen Get with the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get with the Guidelines-Stroke in Taiwan Circulation 122 2010 1116 1123
15. C.H. Lee, P.Y. Liu, and L.M. Tsai Characteristics of hospitalized patients with atrial fibrillation in Taiwan: a nationwide observation Am J Med 120 2007 819.e1 819.e7
16. M. Chang-sheng, and Q. Wenhang Management of atrial fibrillation in Chinese patients CVD Prev Control 4 2009 79 83
17. Q. Gao, X. Fu, and J.W. Wei Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study Int J Stroke 8 2013 150 154
18. G.Y. Lip Atrial fibrillation in 2011: stroke prevention in AF Nat Rev Cardiol 9 2011 71 73
19. D.E. Singer, Y. Chang, and M.C. Fang The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305
20. S. Lee, A.C. Shafe, and M.R. Cowie UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database BMJ Open 1 2011 e000269
21. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
22. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
23. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
24. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
25. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
26. M. Hughes, and G.Y. Lip Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review QJM 100 2007 599 607
27. N.S. Roskell, G.Y. Lip, H. Noack, A. Clemens, and J.M. Plumb Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate Thromb Haemost 104 2010 1106 1115
28. S.J. Connolly, J. Eikelboom, and C. Joyner Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 881
29. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
30. S.J. Connolly, J.W. Eikelboom, and J. Ng Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable Ann Intern Med 155 2011 579 586
31. J. Mant, F.D. Hobbs, and K. Fletcher Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial Lancet 370 2007 493 503
32. L.G. Olsson, K. Swedberg, G. Lappas, S. Stewart, and A. Rosengren Trends in stroke incidence after hospitalization for atrial fibrillation in Sweden 1987 to 2006 Int J Cardiol 167 2013 733 738
33. L. Azoulay, S. Dell'aniello, T.A. Simon, D. Langleben, C. Renoux, and S. Suissa A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study BMC Cardiovasc Disord 12 2012 49
34. J-RHYTHM Registry Investigators Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan. Subanalysis of the J-RHYTHM Registry Circ J 75 2011 2357 2362
35. Chinese Association of cardiovascular disease. Chinese medical doctor association. Specialist consensus on primary prevention for cardiovascular disease Chin J Intern Med 49 2010 174 185
36. L. Friberg, M. Rosenqvist, and G.Y. Lip Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study Circulation 125 2012 2298 2307
37. A.M. Gallagher, E. Setakis, J.M. Plumb, A. Clemens, and T.P. van Staa Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients Thromb Haemost 106 2011 968 977
38. R. Nieuwlaat, B.J. Connolly, and L.M. Hubers Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: a nested case control analysis of the ACTIVE W study Thromb Res 129 2012 715 719
39. G.Y. Lip, T.B. Larsen, F. Skjøth, and L.H. Rasmussen Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation J Am Coll Cardiol 60 May 8 2012 738 746
40. A. Banerjee, D.A. Lane, C. Torp-Pedersen, and G.Y. Lip Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study Thromb Haemost 107 2012 584 589
41. L. Wallentin, S. Yusuf, and M.D. Ezekowitz Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lancet 376 2010 975 983